Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia

Acta Tropica

Volumn 113, Issue 2, 2010, Pages 105-113

  Yeshiwondim, Asnakew K ^a   Tekle, Afework H ^b   Dengela, Dereje O ^c   Yohannes, Ambachew M ^a   Teklehaimanot, Awash ^d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b FEDERAL MINISTRY OF HEALTH   (Ethiopia)

^c Oromia Regional State Health Bureau   (Ethiopia)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Chloroquine; Ethiopia; Plasmodium vivax; Primaquine

Indexed keywords

CHLOROQUINE; PRIMAQUINE;

COMPARATIVE STUDY; DETECTION METHOD; DISEASE TREATMENT; DRUG; MALARIA; MORBIDITY; PARASITIC DISEASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ETHIOPIA; FEMALE; FEVER; FOLLOW UP; HUMAN; INCIDENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PARASITEMIA; PLASMODIUM VIVAX MALARIA; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK ASSESSMENT; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; ETHIOPIA; FEMALE; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PARASITEMIA; PLASMODIUM VIVAX; PRIMAQUINE; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

DEBRE ZEIT; ETHIOPIA; ISRAEL; NAZARETH; NORTHERN DISTRICT;

PLASMODIUM VIVAX;

EID: 74149092769     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2009.10.001     Document Type: Article

References (36)

1. Baird J.K. Chloroquine resistance in Plasmodium vivax. Minireview. Antimicrob. Agents Chemother. 48 11 (2004) 4075-4083
2. Baird J.K. Neglect of Plasmodium vivax malaria. Trends Parasitol. 23 (2007) 533-539
3. Baird J.K., and Hoffman S.L. Primaquine therapy for malaria. J. Infect. Dis. 39 (2004) 136-145
4. Baird J.K., Basri H., Purnomo A.T., Bangs M.J., Subianto B., Patchen C.L., and Hoffman S.L. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 44 (1991) 547-552
5. Baird J.K., Leksana B., Masbar S., Fryauff D.J., Sutanihardja M.A., Suradi D.D., Wignall F.S., and Hoffman S.L. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood levels. Am. J. Trop. Med. Hyg. 56 (1997) 621-626
6. Baird J.K., Leksana B., Masbar S., Suradi A.Y., Sutanihardja M.A., Fryauff D.J., and Subianto B. Whole blood chloroquine concentrations with Plasmodium vivax infection in Iranian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 56 (1997) 618-620
7. Barcus M.J., Basri H., Picarima H., Manyakori C., Sekartuti A.T., Elyazar I., Bangs M.J., Maguire J.D., and Baird J.K. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am. J. Trop. Med. Hyg. 77 (2007) 984-991
8. Bunnag D., Karbwang J., Thanavibul A., Chittamas S., Ratanapongs Y., Chalermrut K., Bangchang K.N., and Harinasuta T. High dose of primaquine in primaquine resistant vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 88 (1994) 218-219
9. Chen N., Auliff A., Rieckmann K.H., Gatton M., and Cheng Q. Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 95 (2007) 934-941
10. Collins W., and Jeffery G.M. Primaquine resistance in Plasmodium vivax. Am. J. Trop. Med. Hyg. 55 (1996) 243-249
11. Genton, B., D'Acremont, V., Rare, L., Baea, K., Reeder, J.C., Alpers, M.P., Müller I., 2008. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 5, e127. doi:10.1371/journal.pmed.0050127.
12. Imwong M., Pukrittayakamee S., Grüner A.C., Rénia L., Letourneur F., Looareesuwan S., White N.J., and Snounou G. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malaria J. 4 (2005) 20
13. Imwong M., Snounou G., Pukrittayakamee S., Tanomsing N., Kim J.R., Nandy A., Guthmann J.P., Nosten F., Carlton J., Looareesuwan S., Nair S., Sudimack D., Day N.P., Anderson T.J., and White N.J. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J. Infect. Dis. 195 (2007) 927-933
14. Jima A., Tesfaye G., Medhin A., Kebede A., Argaw D., and Babaniyi O. Therapeutic efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Ethiopia. East Afr. Med. J. 82 (2005) 391-395
15. Looareesuwan S., Buchachart K., Wilairatana P., Chalermrut K., Rattanapong Y., Amradee S., Siripiphat S., Chullawichit S., Thiamasan K., Ittiverakul M., Triampon A., and Walsh D.S. Primaquine-tolerant vivax malaria in Thailand. Ann. Trop. Med. Parasitol. 91 (1997) 939-943
16. Mendis K., Sina B.J., Marchesini P., and Carter R. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64 (2001) 97-106
17. MoH. Malaria Diagnosis and Treatment Guidelines for Health Workers in Ethiopia. 1st ed. (1999), Ministry of Health of Ethiopia, Addis Ababa, Ethiopia
18. MoH, 2004a. Health and Health Related Indicators for 2003-2004. http://www.moh.gov.et/index.php.
19. MoH, 2004b. Malaria Diagnosis and Treatment guidelines for Health Workers in Ethiopia, 2nd ed., Ministry of Health, Federal Democratic Republic of Ethiopia, Addis Ababa, http://www.moh.gov.et/index.php.
20. Morassin B., Fabre R., Berry A., and Magnaval J.F. One year's experience with the polymerase chain reaction as a routine method for the diagnosis of imported malaria. Am. J. Trop. Med. Hyg. 66 (2002) 503-508
21. Nosten F., McGready R., Simpson J.A., Thwai K.L., Balkan S., Cho T., HKirijaroen L., Looareesuwan S., and White N.J. Effects of Plasmodium vivax malaria in pregnancy. The Lancet 354 (1999) 546-549
22. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., and Anstey N.M. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 77 (2007) 79-87
23. Pukrittayakamee S., Vanijanonta S., Chantra A., Clemens R., and White N.J. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J. Infect. Dis. 169 (1994) 932-935
24. Rieckmann K.H., Davis D.R., and Hutton D.C. Plasmodium vivax resistance to chloroquine?. The Lancet 2 (1989) 1183-1184
25. Ruebush T.K., Zegarra J., Cairo J., Andersen E.M., Green M., Pillai D.R., Marquino W., Huilca M., Arévalo E., Garcia C., Solary L., and Kain K.C. Chloroquine-resistant Plasmodium vivax malaria in Peru. Am. J. Trop. Med. Hyg. 69 (2003) 548-552
26. Schwartz E., and Regev-Yochay G. Primaquine as prophylaxis for malaria for nonimmune travelers: a comparison with mefloquine and doxycycline. Clin. Infect. Dis. 29 (1999) 1502-1506
27. Schwartz E., Regev-Yochay G., and Kurnik D. Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 62 (2000) 393-395
28. Smoak B.L., DeFraites R.F., Magill A.J., Kain K.C., and Wellde B.T. Plasmodium vivax infection in U.S. army troops: failure of primaquine to prevent relapse in studies from Somalia. Am. J. Trop. Med. Hyg. 56 (1997) 231-234
29. Tjitra, E., Anstey, N.M., Sugiarto, P., Warikar, N., Kenangalem, E., et al., 2008. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria. A prospective study in Papua, Indonesia. PLoS Med. 5, e128. doi:10.1371/journal.pmed.0050128.
30. Tulu A. Malaria. In: Kloos H., and Zein Z.A. (Eds). The Ecology of Health and Disease in Ethiopia (1993), Westview Press, Boulder (CO) 341-352
31. Tulu N.A., Webber R.H., Schellenberg A., and Bradley D.J. Failure of chloroquine treatment for malaria in the highlands of Ethiopia. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 556-557
32. WHO, 2001. The use of anti-malarial drugs. Report of a WHO Informal Consultation. WHO/CDS/RBM/2001.33, pp. 34-35.
33. WHO, 2002. Monitoring antimalarial drug resistance. Report of a WHO Consultation. Document WHO/CDS/CSR/EPH/2002.7 and WHO/CDS/RBM/2002.29. WHO, Geneva, Switzerland.
34. WHO, 2005. Susceptibility of Plasmodium falciparum to Antimalarial Drugs: Report on Global Monitoring: 1996-2004, WHO/HTM/MAL/2005.1103. WHO, Geneva, Switzerland.
35. WHO, 2007. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations: informal consultation organized by the Medicines for Malaria Venture and cosponsored by the World Health Organization, 29-31 May 2007, Amsterdam, The Netherlands. WHO, Geneva, Switzerland. Available at: http://apps.who.int/malaria/docs/drugresistance/MalariaGenotyping.pdf.
36. Wilairatana P., Silachamroon U., Krudsood S., Singhasivanon P., Treeprasertsuk S., Bussaratid V., Phumratanaprapin W., Srivilirt S., and Looareensuwan S. Efficacy of primaquine regimens for primaquine resistant Plasmodium vivax malaria in Thailand. Am. J. Trop. Med. Hyg. 61 (1999) 973-977